Immunomodulatory role of histamine H4 receptor in breast cancer
BACKGROUND: Although the role of histamine H4 receptor (H4R) in immune cells is being extensively investigated, its immunomodulatory function in cancer is completely unknown. This study aimed to investigate the role of H4R in antitumour immunity in a model of triple-negative breast cancer. METHODS: We evaluated growth parameters, histological characteristics and the composition of tumour, splenic and tumour draining lymph node (TDLN) immune subsets, in a syngeneic model, developed orthotopically with 4T1 cells in H4R knockout (H4R-KO) and wild-type mice. RESULTS: Mice lacking H4R show reduced tumour size and weight, decreased number of lung metastases and percentage of CD4+ tumour-infiltrating T cells, while exhibiting increased infiltration of NK cells and CD19+ lymphocytes. Likewise, TDLN of H4R-KO mice show decreased CD4+ T cells and T regulatory cells (CD4+CD25+FoxP3+), and increased percentages of NK cells. Finally, H4R-deficient mice show decreased Tregs in spleens and non-draining lymph nodes, and a negative correlation between tumour weight and the percentages of CD4+, CD19+ and NK splenic cells, suggesting that H4R also regulates antitumour immunity at a systemic level. CONCLUSIONS: This is the first report that demonstrates the participation of H4R in antitumour immunity, suggesting that H4R could be a target for cancer treatment.
Main Authors: | , , , , , , |
---|---|
Format: | Artículo biblioteca |
Language: | spa |
Published: |
Springer
2019
|
Subjects: | CANCER DE MAMA, HISTAMINA, INMUNOLOGIA, GENES, BIOLOGIA CELULAR, |
Online Access: | https://repositorio.uca.edu.ar/handle/123456789/8620 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
oai:ucacris:123456789-8620 |
---|---|
record_format |
koha |
spelling |
oai:ucacris:123456789-86202020-10-21T13:33:29Z Immunomodulatory role of histamine H4 receptor in breast cancer Sterle, Helena A. Nicoud, Melisa Beatriz Massari, Noelia A. Táquez Delgado, Mónica Alejandra Herrero Ducloux, María V. Cremaschi, Graciela A. Medina, Vanina Araceli CANCER DE MAMA HISTAMINA INMUNOLOGIA GENES BIOLOGIA CELULAR BACKGROUND: Although the role of histamine H4 receptor (H4R) in immune cells is being extensively investigated, its immunomodulatory function in cancer is completely unknown. This study aimed to investigate the role of H4R in antitumour immunity in a model of triple-negative breast cancer. METHODS: We evaluated growth parameters, histological characteristics and the composition of tumour, splenic and tumour draining lymph node (TDLN) immune subsets, in a syngeneic model, developed orthotopically with 4T1 cells in H4R knockout (H4R-KO) and wild-type mice. RESULTS: Mice lacking H4R show reduced tumour size and weight, decreased number of lung metastases and percentage of CD4+ tumour-infiltrating T cells, while exhibiting increased infiltration of NK cells and CD19+ lymphocytes. Likewise, TDLN of H4R-KO mice show decreased CD4+ T cells and T regulatory cells (CD4+CD25+FoxP3+), and increased percentages of NK cells. Finally, H4R-deficient mice show decreased Tregs in spleens and non-draining lymph nodes, and a negative correlation between tumour weight and the percentages of CD4+, CD19+ and NK splenic cells, suggesting that H4R also regulates antitumour immunity at a systemic level. CONCLUSIONS: This is the first report that demonstrates the participation of H4R in antitumour immunity, suggesting that H4R could be a target for cancer treatment. 2019-08-22T17:28:19Z 2019-08-22T17:28:19Z 2019 Artículo Sterle HA, Nicoud MB, Massari NA, et al. Immunomodulatory role of histamine H4 receptor in breast cancer [en linea]. British Journal of Cancer 2019;120(1):128-138. doi:10.1038/s41416-018-0173-z Registro en: https://repositorio.uca.edu.ar/handle/123456789/8620 0007-0920 (print) 1532-1827 (online) https://repositorio.uca.edu.ar/handle/123456789/8620 10.1038/s41416-018-0173-z 29988113 spa Acceso Abierto. 6 meses de embargo http://creativecommons.org/licenses/by-nc-sa/4.0/ application/pdf Springer British Journal of Cancer 2019;120(1):128-138 |
institution |
UCA |
collection |
DSpace |
country |
Argentina |
countrycode |
AR |
component |
Bibliográfico |
access |
En linea |
databasecode |
dig-uca |
tag |
biblioteca |
region |
America del Sur |
libraryname |
Sistema de bibliotecas de la UCA |
language |
spa |
topic |
CANCER DE MAMA HISTAMINA INMUNOLOGIA GENES BIOLOGIA CELULAR CANCER DE MAMA HISTAMINA INMUNOLOGIA GENES BIOLOGIA CELULAR |
spellingShingle |
CANCER DE MAMA HISTAMINA INMUNOLOGIA GENES BIOLOGIA CELULAR CANCER DE MAMA HISTAMINA INMUNOLOGIA GENES BIOLOGIA CELULAR Sterle, Helena A. Nicoud, Melisa Beatriz Massari, Noelia A. Táquez Delgado, Mónica Alejandra Herrero Ducloux, María V. Cremaschi, Graciela A. Medina, Vanina Araceli Immunomodulatory role of histamine H4 receptor in breast cancer |
description |
BACKGROUND: Although the role of histamine H4 receptor (H4R) in immune cells is being extensively investigated, its
immunomodulatory function in cancer is completely unknown. This study aimed to investigate the role of H4R in antitumour
immunity in a model of triple-negative breast cancer.
METHODS: We evaluated growth parameters, histological characteristics and the composition of tumour, splenic and tumour
draining lymph node (TDLN) immune subsets, in a syngeneic model, developed orthotopically with 4T1 cells in H4R knockout
(H4R-KO) and wild-type mice.
RESULTS: Mice lacking H4R show reduced tumour size and weight, decreased number of lung metastases and percentage of CD4+
tumour-infiltrating T cells, while exhibiting increased infiltration of NK cells and CD19+ lymphocytes. Likewise, TDLN of H4R-KO mice
show decreased CD4+ T cells and T regulatory cells (CD4+CD25+FoxP3+), and increased percentages of NK cells. Finally, H4R-deficient
mice show decreased Tregs in spleens and non-draining lymph nodes, and a negative correlation between tumour weight and the
percentages of CD4+, CD19+ and NK splenic cells, suggesting that H4R also regulates antitumour immunity at a systemic level.
CONCLUSIONS: This is the first report that demonstrates the participation of H4R in antitumour immunity, suggesting that H4R
could be a target for cancer treatment. |
format |
Artículo |
topic_facet |
CANCER DE MAMA HISTAMINA INMUNOLOGIA GENES BIOLOGIA CELULAR |
author |
Sterle, Helena A. Nicoud, Melisa Beatriz Massari, Noelia A. Táquez Delgado, Mónica Alejandra Herrero Ducloux, María V. Cremaschi, Graciela A. Medina, Vanina Araceli |
author_facet |
Sterle, Helena A. Nicoud, Melisa Beatriz Massari, Noelia A. Táquez Delgado, Mónica Alejandra Herrero Ducloux, María V. Cremaschi, Graciela A. Medina, Vanina Araceli |
author_sort |
Sterle, Helena A. |
title |
Immunomodulatory role of histamine H4 receptor in breast cancer |
title_short |
Immunomodulatory role of histamine H4 receptor in breast cancer |
title_full |
Immunomodulatory role of histamine H4 receptor in breast cancer |
title_fullStr |
Immunomodulatory role of histamine H4 receptor in breast cancer |
title_full_unstemmed |
Immunomodulatory role of histamine H4 receptor in breast cancer |
title_sort |
immunomodulatory role of histamine h4 receptor in breast cancer |
publisher |
Springer |
publishDate |
2019 |
url |
https://repositorio.uca.edu.ar/handle/123456789/8620 |
work_keys_str_mv |
AT sterlehelenaa immunomodulatoryroleofhistamineh4receptorinbreastcancer AT nicoudmelisabeatriz immunomodulatoryroleofhistamineh4receptorinbreastcancer AT massarinoeliaa immunomodulatoryroleofhistamineh4receptorinbreastcancer AT taquezdelgadomonicaalejandra immunomodulatoryroleofhistamineh4receptorinbreastcancer AT herreroduclouxmariav immunomodulatoryroleofhistamineh4receptorinbreastcancer AT cremaschigracielaa immunomodulatoryroleofhistamineh4receptorinbreastcancer AT medinavaninaaraceli immunomodulatoryroleofhistamineh4receptorinbreastcancer |
_version_ |
1756275828985954304 |